Tenet Healthcare (NYSE:THC) Director Sells $3,032,030.19 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 15,099 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $200.81, for a total transaction of $3,032,030.19. Following the completion of the sale, the director owned 47,267 shares in the company, valued at $9,491,686.27. This represents a 24.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Tammy Romo also recently made the following trade(s):

• On Wednesday, November 5th, Tammy Romo sold 645 shares of Tenet Healthcare stock. The shares were sold at an average price of $205.20, for a total transaction of $132,354.00.
• On Tuesday, November 4th, Tammy Romo sold 11,756 shares of Tenet Healthcare stock. The stock was sold at an average price of $204.07, for a total transaction of $2,399,046.92.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $204.99 on Friday. The stock’s fifty day simple moving average is $198.15 and its 200 day simple moving average is $175.72. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.27. The company has a market capitalization of $18.02 billion, a PE ratio of 14.05, a PEG ratio of 0.89 and a beta of 1.53. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $217.43.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.37. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The business had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the previous year, the business posted $2.93 EPS. Tenet Healthcare’s revenue for the quarter was up 3.2% on a year-over-year basis. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. On average, research analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently weighed in on THC. JPMorgan Chase & Co. upped their price target on shares of Tenet Healthcare from $190.00 to $200.00 and gave the company an “overweight” rating in a report on Monday, August 4th. Wolfe Research lowered shares of Tenet Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Royal Bank Of Canada increased their target price on Tenet Healthcare from $230.00 to $252.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Wells Fargo & Company boosted their price target on Tenet Healthcare from $200.00 to $238.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Finally, Wall Street Zen upgraded Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Saturday, July 26th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $226.25.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of THC. Crestwood Advisors Group LLC increased its position in shares of Tenet Healthcare by 2.5% during the 3rd quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company’s stock worth $529,000 after purchasing an additional 64 shares during the last quarter. ProShare Advisors LLC grew its stake in shares of Tenet Healthcare by 1.7% in the second quarter. ProShare Advisors LLC now owns 4,118 shares of the company’s stock valued at $725,000 after buying an additional 67 shares in the last quarter. US Bancorp DE increased its holdings in Tenet Healthcare by 0.8% during the first quarter. US Bancorp DE now owns 8,620 shares of the company’s stock worth $1,159,000 after buying an additional 68 shares during the last quarter. Quadcap Wealth Management LLC lifted its stake in Tenet Healthcare by 1.7% in the second quarter. Quadcap Wealth Management LLC now owns 4,099 shares of the company’s stock valued at $721,000 after acquiring an additional 69 shares during the last quarter. Finally, Andina Capital Management LLC grew its position in shares of Tenet Healthcare by 2.1% in the 3rd quarter. Andina Capital Management LLC now owns 3,360 shares of the company’s stock valued at $682,000 after acquiring an additional 69 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.